COPD: Chronic Obstructive Pulmonary Disease Guide
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition affecting approximately 1.2 million people in the UK, with many more undiagnosed. It is the second most common lung disease in the UK after asthma. This guide covers NHS diagnosis, treatment options, and living well with COPD.
⚡ KEY FACTS
- UK prevalence: 1.2 million diagnosed; estimated 3 million undiagnosed
- Main cause: Smoking accounts for approximately 80% of COPD cases
- Diagnosis: Spirometry showing FEV1/FVC ratio below 0.70 post-bronchodilator
- Treatment: Inhalers, pulmonary rehabilitation, smoking cessation
- Prognosis: Progression can be significantly slowed by stopping smoking
TABLE OF CONTENTS
What is COPD?
COPD is an umbrella term for two related conditions — chronic bronchitis and emphysema — that cause airflow obstruction which is not fully reversible. In chronic bronchitis, the airways become inflamed and produce excess mucus. In emphysema, the air sacs (alveoli) in the lungs are destroyed, reducing the surface area for oxygen exchange.
Unlike asthma, airflow obstruction in COPD is largely irreversible, although symptoms can be improved with treatment. COPD is a leading cause of hospital admissions in England and is responsible for approximately 30,000 deaths per year.
⚠️ COPD is Often Undiagnosed
Around 2 million people in the UK are thought to have undiagnosed COPD. Many dismiss breathlessness as a normal part of ageing or smoking. If you have persistent breathlessness, cough, or frequent chest infections, speak to your GP about a spirometry test.
Symptoms of COPD
COPD symptoms develop gradually and are often initially dismissed. The main symptoms include:
- Breathlessness — initially on exertion, later at rest in severe COPD
- Chronic cough — persistent, often worse in the morning
- Increased sputum production — regular mucus or phlegm
- Frequent chest infections — two or more per year
- Wheeze — particularly during physical activity
- Fatigue — reduced energy levels
- Weight loss — in severe COPD due to increased effort of breathing
Symptoms are graded using the MRC dyspnoea scale (1–5) and categorised by severity using GOLD criteria based on spirometry results.
Causes and Risk Factors
The primary cause of COPD in the UK is cigarette smoking, accounting for around 80% of cases. However, not all smokers develop COPD — genetic susceptibility (including alpha-1 antitrypsin deficiency) plays a role.
Other risk factors include long-term exposure to occupational dusts and chemicals (coal dust, silica, grain dust, isocyanates), indoor air pollution from biomass fuel burning, and a history of severe childhood respiratory infections.
NHS Diagnosis of COPD
NICE guidelines (NG115) recommend spirometry for all patients with suspected COPD. A diagnosis is confirmed by post-bronchodilator spirometry showing a FEV1/FVC ratio of less than 0.70.
COPD severity is classified based on FEV1 as a percentage of predicted:
- GOLD 1 (mild): FEV1 ≥80% predicted
- GOLD 2 (moderate): FEV1 50–79% predicted
- GOLD 3 (severe): FEV1 30–49% predicted
- GOLD 4 (very severe): FEV1 <30% predicted
Additional tests may include chest X-ray (to exclude other causes), CT scan, full lung function tests, and blood tests including alpha-1 antitrypsin levels, particularly in younger patients or those who have never smoked.
NHS Treatment Options
Smoking Cessation
Stopping smoking is the most effective intervention for slowing COPD progression. The NHS offers free Stop Smoking Services, which include counselling, nicotine replacement therapy (patches, gum, inhalers), and prescription medications such as varenicline (Champix) or bupropion.
Bronchodilator Inhalers
Short-acting bronchodilators (SABAs such as salbutamol, or SAMAs such as ipratropium) are used for immediate relief. Long-acting bronchodilators (LABAs and LAMAs, such as tiotropium) are the cornerstone of maintenance therapy. Combination LABA/LAMA inhalers are available for those with more severe symptoms.
Inhaled Corticosteroids
ICS/LABA combination inhalers are recommended for patients with ≥2 moderate exacerbations per year or blood eosinophil counts ≥300 cells/microlitre. Triple therapy (ICS/LABA/LAMA) is used for patients with high symptom burden despite dual therapy.
Vaccinations
All COPD patients should receive the annual influenza vaccine and a one-off pneumococcal vaccine, as respiratory infections are a major cause of exacerbations. COVID-19 vaccination is also strongly recommended.
Pulmonary Rehabilitation
Pulmonary rehabilitation (PR) is a structured 6–8 week programme of exercise and education that is one of the most cost-effective interventions for COPD. It significantly improves exercise capacity, quality of life, and reduces hospital admissions.
Ask your GP or respiratory team for a referral. PR is available free on the NHS for those with moderate to very severe COPD (MRC grade 3–5). Sessions typically run twice a week and include supervised exercise, education on breathing techniques, and self-management skills.
🏃 Exercise is Key
Regular physical activity, even simple walking, is crucial for COPD management. People with COPD who are more physically active have lower rates of hospital admission and better survival. Your pulmonary rehabilitation team will advise on safe exercise levels.
Managing COPD Exacerbations
A COPD exacerbation is a sudden worsening of symptoms, usually triggered by a respiratory infection. Signs include increased breathlessness, more sputum, or a change in sputum colour to yellow or green.
🚨 When to Seek Emergency Help
- Sudden, severe breathlessness at rest
- Cyanosis (blue lips or fingertips)
- Confusion or drowsiness due to reduced oxygen
- Breathing becoming very shallow and rapid
Many patients with moderate or severe COPD are given a rescue pack by their GP — containing antibiotics and oral steroids — to start at home at the first signs of an exacerbation. Discuss this with your GP if you have not been given one.
Frequently Asked Questions
Frequently Asked Questions
Can COPD be reversed?
COPD cannot be reversed — the lung damage is permanent. However, stopping smoking is the single most important step and can prevent further deterioration. Treatments including inhalers, pulmonary rehabilitation, and medication can significantly improve symptoms, increase exercise tolerance, and improve overall quality of life.
How is COPD diagnosed?
COPD is diagnosed through a spirometry test, which measures how much air you can exhale and how quickly. Your GP may also arrange a chest X-ray and blood tests. A diagnosis of COPD is confirmed when spirometry shows persistent airflow limitation (FEV1/FVC ratio below 0.70 after a bronchodilator).
What NHS support is available for people with COPD?
NHS support includes bronchodilator and corticosteroid inhalers, pulmonary rehabilitation programmes (combining exercise and education), annual flu and pneumococcal vaccinations, smoking cessation support, supplemental oxygen therapy if required, and COPD specialist nurse support. A COPD review with your GP or nurse should happen at least once a year.